MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
5 Multiline Insurers to Watch as Pandemic Impact Recedes
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, ORI and HMN as the impact of the pandemic recedes.
MetLife (MET) Unit Hits Milestone in Agricultural Mortgage Loans
by Zacks Equity Research
MetLife (MET) business unit MetLife Investment Management (MIM) creates a record by originating $6 billion in agricultural mortgage loans during 2021.
MetLife (MET) Ties Up to Offer Better Pet Care With New Program
by Zacks Equity Research
MetLife (MET) collaborates with LifeBalance for launching MyPets rewards program in a bid to offer pet parents substantial savings while purchasing pet care commodities.
MetLife's (MET) Structured Solution to Offer Financial Security
by Zacks Equity Research
MetLife (MET) launches a Structured Installment Sale solution with an aim to offer a guaranteed periodic income and defer tax liability of the sellers of qualified properties.
Why Is MetLife (MET) Down 1.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife (MET) Offers Employers Aura's Digital Security Solutions
by Zacks Equity Research
MetLife (MET) forges an alliance with Aura to safeguard the digital identity of employees, having access to its U.S. Group Benefits platform, with the latter's solutions.
Owl Rock Capital (ORCC) Q4 Earnings Beat Mark, Jump Y/Y
by Zacks Equity Research
Owl Rock Capital's (ORCC) fourth-quarter results are supported by an increase in the debt investment portfolio.
AMERISAFE (AMSF) Earnings Break Even in Q4, Revenues Lag
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter results hurt by fall in revenues, soft underwriting results and increasing expenses.
Insurance ETFs to Rally on Solid Q4 Earnings
by Sweta Killa
Some of the prominent players in the insurance industry surpassed estimates for both earnings and revenues.
Top Analyst Reports for Alphabet, Texas Instruments & Linde
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Texas Instruments Incorporated (TXN), and Linde plc (LIN).
MetLife (MET) Extends Solution to Aid Bangladesh Consumers
by Zacks Equity Research
MetLife (MET) launches its cutting-edge 360Health solution in Bangladesh with an aim to empower the country's customers to effectively tackle critical illnesses.
Zacks Value Trader Highlights: Comerica, MetLife, The Mosaic Company, The Andersons, Diamondback Energy
by Zacks Equity Research
Comerica, MetLife, The Mosaic Company, The Andersons, Diamondback Energy are included in this blog.
What's Working in 2022? Value Stocks
by Tracey Ryniec
They're mocked, laughed at and ignored but value stocks have been red-hot in 2022.
American Financial (AFG) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
American Financial's (AFG) fourth-quarter results reflect top-line growth stemming from higher net investment income. Better underwriting results in Specialty P&C Group remain noteworthy.
Voya Financial (VOYA) Q4 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Voya Financial's (VOYA) fourth-quarter results benefit from reduced expenses, partly offset by a fall in premiums and fee income.
MetLife's (MET) Q4 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
MetLife's (MET) fourth-quarter earnings results reflect significant contributions from MetLife Holdings, Latin America and Asia.
MetLife (MET) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 52.82% and 19.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stock Q4 Earnings Due Feb 2: MET, AFL, ALL & LNC
by Kaibalya Pravo Dey
Amid accelerated economic growth and an improved pricing scenario, four Insurance stocks ¿¿¿ MET, AFL, ALL & LNC ¿¿¿ are set to report fourth-quarter results on Feb 2.
Kemper (KMPR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of -365.91% and 0.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Lower Net Investment Income Hurt MetLife (MET) Q4 Earnings?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to reflect volume growth and sound contribution from the Latin America segment.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Unit Assumes U.K. Pension Scheme's Longevity Risks
by Zacks Equity Research
Aided by Zurich, MetLife's (MET) subsidiary completes a reinsurance deal with an aim to boost its presence in the U.K. longevity risk transfer market.
MetLife (MET) Up 12.8% in Past Month: More Growth Ahead?
by Zacks Equity Research
MetLife's (MET) cost-control initiatives are likely to lower expenses and boost profit levels.
MET vs. AIG: Which Multiline Insurance Stock is Better Off?
by Zacks Equity Research
Improved pricing in 2022 is likely to support premium growth for multiline insurance players, going forward. Let's find out whether MET or AIG is better poised to capitalize on the favorable scenario.
The Zacks Analyst Blog Highlights: Microsoft, Broadcom, Eli Lilly, Intuitive Surgical and MetLife
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Broadcom, Eli Lilly, Intuitive Surgical and MetLife.